glomeruli. No immune deposits were detected. She was diagnosed with GPA on the basis of the above conditions. Results.-Thereafter, her renal function improved with BVAS 12. The titer of PR3-ANCA lowered gradually till undetected.
Introduction.-GPA, a small-sized-vessel vasculitis, commonly involves ear, nose & throat (ENT), lungs and kidneys, and rarely, the CNS. The presentation, management and outcome of GPA CNS involvement were evaluated.
Patients.-We retrospectively reviewed the charts of 16 patients (12 men) with: GPA satisfying ACR and/or Chapel Hill criteria; and, after excluding other causes, GPA CNS involvement manifesting as pachymeningitis, meningitis, stroke, spinal cord involvement or hypophyseal involvement.
Results.-Mean respective ages at GPA diagnosis and onset of CNS involvement were 43 and 47 years. The latter was present in nine (56%) patients at GPA diagnosis, and appeared in the seven others after a median follow-up of 24 months. Headache was the main symptom (67%), with motor and sensory impairments noted in 33 and 27%, respectively. CNS involvements were: pachymeningitis (n = 8: seven cranial and one spinal cord), ischemic (n = 4) or hemorrhagic stroke (n = 2), cerebral vasculitis (n = 2), and/or hypophyseal involvement (n = 2). Extra-CNS manifestations included ENT (75%), lungs (60%), peripheral nerve(s) (40%) and kidneys (33%). ANCA detected in 12/16 (75%) patients had PR3 (n = 7) or MPO (n = 5) specificity. Induction therapy comprised corticosteroids (CS, 100%) and IV (69%) or oral cyclophosphamide (CYC, 25%) or rituximab (6%). Maintenance therapy consisted of CS (100%) and azathioprine (63%), or methotrexate or rituximab (13% each). CNS involvement responded clinically in 12/16 (75%). Relapsing and/ or refractory CNS GPA in seven patients was treated with IV CYC or rituximab (43% each) or oral CYC (14%). No patient died during followup, but 64% had persistent neurological sequelae. Conclusion.-Our series highlights the heterogeneity of CNS involvement in GPA. Despite initial severe disease, conventional therapy obtained clinical improvement in 75% of the patients. Rituximab should be evaluated for refractory and/or relapsing CNS GPA. Results.-Pituitary involvement was noted in nine patients (five women). Median age at diagnosis of both GPA and pituitary involvement was 48 (range 28-68). All patients were c-ANCA/PR3 positive. Pituitary involvement frequently represented an incidental imaging finding during the evaluation of headache or sinusitis (six patients). Three patients presented with symptoms of pituitary dysfunction. ENT disease, pulmonary and kidney involvement were present in nine, six and four patients, respectively. None of the patients had isolated pituitary involvement. Diabetes insipidus (DI) was detectable in seven patients but was commonly asymptomatic. Eight patients had hypogonadism, five hypothyroidism, two hypocortisolism, and one had normal anterior pituitary function with isolated DI. Head MRI revealed a sellar mass with peripheral enhancement or diffuse pituitary enlargement in all patients. Complete remission of GPA was seen in all, after treatment with cyclophosphamide and rituximab in seven and two patients, respectively. After a median follow up of 80 months (range 6-128), all but one patient had decrease in size of the pituitary enlargement within 1 year of treatment. DI resolved in five out of seven patients, and persisted in the other two. Of the eight patients with anterior pituitary dysfunction, resolution was seen in three, improvement in three, and persistent dysfunction in two patients. Conclusion.-Pituitary involvement is an uncommon manifestation of GPA and occurs concomitantly with other organ involvement. Introduction.-Rhinosinusitis (RS) is the most common manifestation of granulomatosis with polyangiitis (GPA). Standardized tools to evaluate disease extension and to monitor therapy response are needed. Sinus computed tomography (SCT) is the preferred imaging modality for evaluating RS. Many staging systems exist to quantify RS based on SCT; Lund-Mackay staging (LMS) and Newman staging (NS) systems are the most reproducible and simple in infectious/allergic RS. Purpose.-To determine the reproducibility of LMS and NS between evaluators of different specialties and level of expertise in the evaluation of RS in GPA.
Patients.-Retrospective evaluation of 15 patients with sinonasal GPA and 15 subjects with non-vasculitic rhinosinusitis (NVRS) was performed. SCT were reviewed by six evaluators from different specialties [radiology (n = 2), rheumatology (n = 2) and ENT (n = 2)] and level of expertise (one staff and one resident in each specialty), all blinded to the clinical diagnosis. Evaluators reviewed the published LMS and NS scores and received a brief training to apply it. Results are expressed as median (range) and analyzed with Pearson test for correlation and Mann-Whitney to compare medians.
Results.-GPA and NVRS groups were similar in gender (50% female), age [60 (28-68) vs. 56 (25-67) 
